TADLIQ 20 MG/5 ML SUSPENSION
FDA nonproprietary name: tadalafil
For 150 mL
Pharmacies pay
$2,038.97 filed
150 × $13.59311 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-10-01 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$1,832.92 filed
150 × $12.21944 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.90× estimated
Medicare paid 10% less than pharmacies pay.
Part D averages every strength and form sold under “Tadliq” / “Tadalafil” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-10-01 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$2,349.82 estimated
$2,038.97 + $305.85 (15%) + $5.00 fee per fill = $2,349.82
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-10-01 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
TADLIQ 20 MG/5 ML SUSPENSION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tadalafil, under the trade name “TADLIQ”.
FDA gives its dosage form as suspension and its route as oral.
The labeler, the company named on the label, is CMP Pharma, Inc.
FDA’s Established Pharmacologic Class for it is Phosphodiesterase 5 Inhibitor.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 46287-0045-15.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2,038.97 for 150 mL (150 × $13.59311 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-10-01. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 3, the survey-based NADAC was adjusted for changes in published pricing, or after a help-desk inquiry; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The NDC
- 46287-0045-15 · CMP Pharma, Inc. · $13.59311 per ML · eff. 2026-10-01 filed
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name tadalafil with TADLIQ 20 MG/5 ML SUSPENSION.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ALYQ 20 MG TABLET | $0.14633 per EA filed | $17.34198 per EA filed |
| CIALIS 5 MG TABLET | $9.20446 per EA filed | $9.68261 per EA filed |
| CIALIS 10 MG TABLET | $53.6874 per EA filed | $9.68261 per EA filed |
| CIALIS 20 MG TABLET | $53.82543 per EA filed | $9.68261 per EA filed |
| TADALAFIL 2.5 MG TABLET | $0.11265 per EA filed | We don’t know yet |
| TADALAFIL 5 MG TABLET | $0.10319 per EA filed | We don’t know yet |
| TADALAFIL 10 MG TABLET | $0.15341 per EA filed | We don’t know yet |
| TADALAFIL 20 MG TABLET | $0.14633 to $0.16709 per EA filed | We don’t know yet |
| TADLIQ 20 MG/5 ML SUSPENSION this page | $13.59311 per ML filed | $12.21944 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23, 2026-10-01 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $1,832.92 for 150 mL, at an average of $12.21944 per ML in 2024 (2024-01-01 to 2024-12-31) for “Tadliq” and “Tadalafil”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 71 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 150 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 150 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for TADLIQ 20 MG/5 ML SUSPENSION labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Tadliq / Tadalafil: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 150 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 150 mL in one package for this product’s NDC (“150 mL in 1 BOTTLE (46287-045-15)”), so the card starts at one package: 150 ML. Change it to match your prescription.